MedTech Dive September 25, 2024
Susan Kelly

Michelle Brennan was named acting CEO of the patient monitoring company following Joe Kiani’s defeat in a proxy battle with an activist investor.

Dive Brief:

  • Masimo CEO and founder Joe Kiani resigned from the company after losing his board seat last week in a proxy battle with Politan Capital Management.
  • Former Johnson & Johnson executive Michelle Brennan, who was elected to Masimo’s board last year with Politan’s support, was named interim CEO effective immediately, according to a Wednesday announcement.
  • Masimo reaffirmed its financial guidance for the third quarter on a non-GAAP basis. CFO Micah Young and Chief Operating Officer Bilal Muhsin said they would provide more details on an earnings call in October.

Dive Insight:

Kiani’s resignation 35...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Medical Devices
Related Articles:
Sonio Announces Official Acquisition By Samsung After French Ministry of the Economy and Finance Approval
Report Says DME Investment Could Save Medicare $200B Annually
Neurable launches smart brain-computer interface headphones with Master & Dynamic
Route 92 Medical raises $50M to fund global sales of stroke devices
A New Dimension: Inside the drug delivery wearable inspired by technology developed at NASA

Share This Article